1. Please rate the overall quality of the following elements of the virtual meeting.
2. In your opinion, has the feedback from the pre-meeting survey been considered?
3. Did the expert meeting achieve its overall objectives?
4. Did the discussions explain how to successfully implement gene panel testing for the diagnosis of skeletal dysplasia?
5. What is your opinion on the quality of discussion on:
6. In your opinion, were there important discussion points missing in the programme?
8. Would you consider participating in future advisory board meetings for this product/disease area hosted by BioMarin?